H.R. 3820 · 116th Congress
Effective Drug Control Strategy Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
20 cosponsors · 11 D, 9 R
8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Office of National Drug Control Policy to (1) evaluate the effectiveness of all federally funded activities aimed at reducing the demand for illegal drugs, and (2) publish annually a complete list of all drug control grant programs.
What it does: CRS summary · Introduced in House · Jul 18, 2019
Effective Drug Control Strategy Act
This bill requires the Office of National Drug Control Policy to (1) evaluate the effectiveness of all federally funded activities aimed at reducing the demand for illegal drugs, and (2) publish annually a complete list of all drug control grant programs.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Effective Drug Control Strategy Act
Latest action (Jul 19, 2019): Referred to the Subcommittee on Health.
Policy area: Crime and Law Enforcement · Origin: House · Introduced: Jul 18, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.